:::

詳目顯示

回上一頁
題名:從乳房MRI圖像研究使用補充性雌激素的影像差異
書刊名:醫學與健康期刊
作者:林水龍 引用關係梁庭繼周紋郁
作者(外文):Lin, Shoei-loongLiang, Ting-chiChou, Wen-yu
出版日期:2014
卷期:3:2
頁次:頁105-113
主題關鍵詞:乳房核磁共振攝影雌激素賀爾蒙影響植物性激素乳腺增生Breast MRIEstrogenHormone effectPhytoestrogenProliferative breast glandular tissue
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:8
MRI有高敏感度可以提早發現乳腺組織異常。通常用於識別一個部位的增殖,血管增生(angiogenesis)及微血管的通透性(microvascular permeability),這可能表示早期乳腺腫瘤的形成。我們回顧了2005年台灣婦女的乳房MRI圖像,根據BI-RADS分類,將分為健康或不健康或需要覆檢。在我們的研究中,部分患者至少接受3個月含有雌激素成分或植物雌激素的雌激素補充劑。這些病人的影像也被分為健康或不健康或需要覆檢的群體。比較這兩組發現之間的有顯著性差異(P<0.002)。某些情況下,比較MRI圖像,還可發現典型的雌激素/植物雌激素作用或撤回效果。MRI圖像上,反映過度使用雌激素或植物雌激素補充劑,會增加乳房的腺體組織增生。此增生可能會增加未來的乳癌患者的風險。
MRI provides a highly sensitive technique for early detection of abnormal breast tissue. It is useful for identifying a status of proliferation, angiogenesis, and microvascular permeability, which may indicate early breast neoplasm formation. We retrospectively studied 2005 breast MRI images from Taiwanese women and classified them as either healthy or unhealthycall backs for re-examination, according to BI-RADS categories. A subgroup of our study patients had received estrogen supplements, containing estrogen components or phytoestrogen, for at least 3 months. These patients' images were also classified into the unhealthycall backs for re-examination groups. These two groups were compared and a significant difference was found between them (P<0.002). Comparison of the MRI images also identified certain cases in which there was a typical estrogen/phytoestrogen effect or a withdrawal effect. The overuse of estrogen or phytoestrogen supplements can increase breast glandular tissue proliferation, as reflected on MRI images. Such proliferation may increase the patient's risk of future breast cancer.
期刊論文
1.Katalinic, A.、Rawal, R.(2008)。Epidemiology decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy。Br Ca Res Tr,107,427-430。  new window
2.Leung, T. K.、Huang, P. J.、Chen, C. S.、Lin, Y. H.、Wu, C. H.、Lee, C. M.(2010)。Is breast MRI screening more effective than digital mammography in Asian women。Journal of Experimental & Clinical Medicine,2,245-250。  new window
3.Erguvan-Dogan, B.、Whitman, G. J.、Kushwaha, A. C.、Phelps, M. J.、Dempsey, P. J.(2006)。BI-RADS-MRI: A primer。American J Roentg,187,152-160。  new window
4.Liberman, L.、Menell, J. H.(2002)。Breast imaging reporting and data system (BI-RADS)。Radiol Clin North Am,40,409-430。  new window
5.Leung, T. K.、Chu, J. S.、Huang, P. J.(2010)。Breast MRI for monitoring images of an adenomyoepithelioma with malignant features, before, during, and after chemotherapy。Breast Journal,16,652-653。  new window
6.Leung, T. K.、Huang, P. J.、Lee, C. M.、Chen, C. S.、Wu, C. H.、Chao, J. S.(2010)。Can breast magnetic resonance imaging demonstrate characteristic findings of preoperative ductal carcinoma in situ in Taiwanese women。Asian Journal of Surgery,33,143-149。  new window
7.Leung, T. K.、Huang, P. J.、Lee, C. M.、Chen, C. S.(2012)。Silicone breast implant with intracapsular rupture coexis- ting with locally advanced carcinoma。Breast Journal,18,76-77。  new window
8.Key, T. J.、Chen, J.、Wang, D. Y.、Pike, M. C.、Boreham, J.(1990)。Sex hormones in women in rural China and in。Brist J Ca,62,631-636。  new window
9.Clemons, M.、Goss, P.(2001)。Estrogen and the risk of breast cancer。N Eng J Med,344,276-285。  new window
10.Tsai, A. C.、Liou, J. C.、Chang, M. C.、Chuang, Y. L.(2007)。Influence of diet and physical activity on aging associated body fatness and anthropometric changes in older Taiwanese。Nut Res,27,245-251。  new window
11.Hsieh, S. C.、Lai, J. N.、Lee, C. F.、Hu, F. C.、Tseng, W. L.、Wang, J. D.(2008)。The prescribing of Chinese herbal products in Taiwan: A cross-sectional analysis of the national health insurance reimbursement database。Pharmaco epidemiological Drug Safety,17,609-619。  new window
12.Dupont, W. D.、Page, D. L.(1985)。Risk factors for breast cancer in women with proliferative breast disease。N Eng J Med,312,146-151。  new window
13.Hsieh, C. Y.、Santell, R. C.、Haslam, S. Z.、Helferich, W. G.(1998)。Estrogenic effects of genistein on the growth of estrogen receptorpositive human breast cancer (MCF- 7) cells in vitro and in vivo。Ca Res,58,3833-3838。  new window
14.Zava, D. T.、Duwe, G.(1997)。Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro。Nut Ca,27,31-40。  new window
15.Wang, T. T.、Sathyamoorthy, N.、Phang, J. M.(1996)。Molecular effects of genistein on estrogen receptor mediated pathways。Carcinogenesis,17,271-275。  new window
16.Yager, J. D.、Davidson, N. E.(2006)。Estrogen carcinogenesis in breast cancer。N Eng J Med,354,270-282。  new window
17.Peeters, P. H. M.、Keinan-Boker, L.、van der Schouw, Y. T.、Grobbee, D. E.(2003)。Phytoestrogens and breast cancer risk: Review of the epidemiological evidence。Br Ca Res Tr,77,171-183。  new window
18.Keinan-Boker, L.、van der Schouw, Y. T.、Grobbee, D. E.、Peeters, P. H. M.(2004)。Dietary phytoestrogens and breast cancer risk。American J Clin Nut,79,282-288。  new window
19.Duffy, C.、Perez, K.、Partridge, A.(2007)。Implications of phytoestrogen intake for breast cancer。Ca Cancer J Clin,57,260-277。  new window
20.Bouker, K. B.、Hilakivi-Clarke, L.(2000)。Genistein: Does it prevent or promote breast cancer?。Environ Health Perspect,108,701-708。  new window
21.Mayo, J. L.(1997)。A Natural approach to menopause。Clin Nut Insig,5,1-8。  new window
22.Yap, S. P.、Shen, P.、Li, J.、Lee, L. S.、Yong, E. L.(2007)。Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium。J Ethnopharmacol,113,218-224。  new window
23.Wang, Z. Q.、Lou, Y. J.(2004)。Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells。Europ J Pharm,504,147-153。  new window
圖書
1.Stephens, T. W.(1998)。Illustrated breast imaging reporting and data system (BI-RADS)。Reston:American College of Radiology。  new window
2.Huang, K. C.(1993)。The pharmacology of Chinese herbs。Boca Raton:CRC Press。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE